# Fulminant Course of Crohn’s Disease: A Case Report on Necrotizing Fasciitis and Septic Shock as Lethal Complications

## TL;DR

A 39-year-old man with Crohn's disease developed a rare and fatal infection called necrotizing fasciitis, highlighting the risks of severe complications in immunocompromised patients.

## Contribution

This case report documents a rare and fatal progression of Crohn's disease to necrotizing fasciitis and septic shock.

## Key findings

- Necrotizing fasciitis can develop in Crohn's disease patients with perianal involvement and surgical history.
- Multidrug-resistant organisms, such as vancomycin- and linezolid-resistant enterococci, complicate treatment outcomes.
- Despite aggressive treatment, the patient succumbed to septic shock, emphasizing the severity of this complication.

## Abstract

Necrotizing fasciitis (NF) is a rare but potentially fatal soft tissue infection that presents a particular challenge in immunocompromised individuals, including patients with Crohn's disease (CD). Although perianal manifestations are common in CD, progression to NF remains exceedingly rare. We report the case of a 39-year-old man with CD, complicated by perianal involvement, multiple surgical interventions, and a loop colostomy. The patient presented with right lower extremity pain and edema, with imaging indicating extensive subcutaneous and fascial inflammation consistent with NF. Emergent surgical debridement and broad-spectrum antibiotic therapy were initiated; however, despite intensive care management and escalation of antimicrobial therapy, the patient’s condition continued to deteriorate. Cultures identified a polymicrobial infection including vancomycin- and linezolid-resistant enterococci (VLRE). The patient ultimately succumbed to septic shock. This case highlights the potential for atypical and fatal infectious complications in patients with long-standing CD, particularly those undergoing immunosuppressive therapy and repeated surgical interventions. Timely diagnosis and aggressive management are crucial for improving outcomes in NF; however, treatment is often complicated by diagnostic delays, rapid clinical deterioration, and the emergence of multidrug-resistant organisms, all of which pose significant therapeutic challenges.